Long non-coding RNA-PCGEM1 contributes to prostate cancer progression by sponging microRNA miR-129-5p to enhance chromatin licensing and DNA replication factor 1 expression-Reference-Cited by-同舟云学术

Long non-coding RNA-PCGEM1 contributes to prostate cancer progression by sponging microRNA miR-129-5p to enhance chromatin licensing and DNA replication factor 1 expression

Published:2022-04-01 Issue:4 Volume:13 Page:9411-9424
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Fu Qiao¹,Wang Fangfang¹,Yang Jun¹,Sun Wei¹,Hu Zhi¹,Xu Lv¹,Chu Hao¹,Wang Xiao¹,Zhang Wei¹

Affiliation:

1. Department of Urology, The Third Hospital of Wuhan, Wuhan Hubei, China

Funder

Wuhan Key Project of Research on the Molecular Phenotype Spectrum Identification and Clinical Application Evaluation of Circulating Prostate Cancer Cells

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2022.2059936

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. The Epidemiology of Prostate Cancer

3. Epidemiology of Prostate Cancer

4. The genetic epidemiology of prostate cancer and its clinical implications

5. Beyond the RNA-dependent function of LncRNA genes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Value of Emerging Prostate Cancer-associated lncRNA PCGEM1 in Various Tumors;Mini-Reviews in Medicinal Chemistry;2023-12

2. A thorough understanding of the role of lncRNA in prostate cancer pathogenesis; Current knowledge and future research directions;Pathology - Research and Practice;2023-08